SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
19-Sep-22 9:53 PM View: | Roivant Sciences Ltd. (ROIV) | 15-Sep-22 | Grant | 52,142 | -- | -- | 100% 0 to 52.14K | |
03-Jan-22 7:57 PM View: | Bridgebio Pharma, Inc. (BBIO) | 30-Dec-21 | Market Purchase | 1,500 | $14.30 | $21,450.00 | < 1% 252.18K to 253.68K | 2% |
03-Jan-22 7:57 PM View: | Bridgebio Pharma, Inc. (BBIO) | 29-Dec-21 | Market Purchase | 6,000 | $12.90 | $77,400.00 | 2% 246.18K to 252.18K | 13% |
07-Dec-21 3:17 PM View: | Abcellera Biologics Inc. (ABCL) | 03-Dec-21 | Market Purchase | 86,938 | $14.02 | $1,218,870.00 | 100% 0 to 86.94K | (4%) |
19-Jun-19 6:20 PM View: | Urovant Sciences Ltd. (UROV) | 19-Jun-19 | Market Purchase (Planned) Duplicate | 4,957 | $8.17 | $40,495.20 | < 1% 22.86M to 22.86M | 99% |
19-Jun-19 6:20 PM View: | Urovant Sciences Ltd. (UROV) | 18-Jun-19 | Market Purchase (Planned) Duplicate | 6,706 | $8.21 | $55,061.00 | < 1% 22.85M to 22.86M | 98% |
19-Jun-19 6:20 PM View: | Urovant Sciences Ltd. (UROV) | 17-Jun-19 | Market Purchase (Planned) Duplicate | 6,541 | $8.53 | $55,824.80 | < 1% 22.84M to 22.85M | 90% |
14-Jun-19 6:30 PM View: | Urovant Sciences Ltd. (UROV) | 14-Jun-19 | Market Purchase Duplicate | 7,144 | $7.91 | $56,514.00 | < 1% 22.83M to 22.84M | 105% |
14-Jun-19 6:30 PM View: | Urovant Sciences Ltd. (UROV) | 13-Jun-19 | Market Purchase Duplicate | 7,367 | $7.95 | $58,542.60 | < 1% 22.83M to 22.83M | 104% |
14-Jun-19 6:30 PM View: | Urovant Sciences Ltd. (UROV) | 12-Jun-19 | Market Purchase Duplicate | 7,500 | $8.30 | $62,244.00 | < 1% 22.82M to 22.83M | 95% |
11-Jun-19 6:05 PM View: | Urovant Sciences Ltd. (UROV) | 11-Jun-19 | Market Purchase (Planned) Duplicate | 7,189 | $8.58 | $61,693.80 | < 1% 22.81M to 22.82M | 89% |
11-Jun-19 6:05 PM View: | Urovant Sciences Ltd. (UROV) | 10-Jun-19 | Market Purchase (Planned) Duplicate | 7,500 | $8.35 | $62,594.20 | < 1% 22.81M to 22.81M | 94% |
11-Jun-19 6:05 PM View: | Urovant Sciences Ltd. (UROV) | 07-Jun-19 | Market Purchase (Planned) Duplicate | 6,649 | $7.97 | $52,959.30 | < 1% 22.8M to 22.81M | 104% |
06-Jun-19 6:08 PM View: | Urovant Sciences Ltd. (UROV) | 06-Jun-19 | Market Purchase (Planned) Duplicate | 7,082 | $8.00 | $56,621.30 | < 1% 22.79M to 22.8M | 103% |
06-Jun-19 6:08 PM View: | Urovant Sciences Ltd. (UROV) | 05-Jun-19 | Market Purchase (Planned) Duplicate | 6,540 | $8.02 | $52,418.10 | < 1% 22.78M to 22.79M | 102% |
06-Jun-19 6:07 PM View: | Myovant Sciences Ltd. (MYOV) | 04-Jun-19 | Private Purchase Duplicate | 2,424,240 | $8.25 | $20,000,000.00 | 6% 38.34M to 40.77M | |
06-Jun-19 6:08 PM View: | Urovant Sciences Ltd. (UROV) | 04-Jun-19 | Market Purchase (Planned) Duplicate | 7,500 | $7.59 | $56,910.80 | < 1% 22.78M to 22.78M | 114% |
03-Jun-19 6:13 PM View: | Urovant Sciences Ltd. (UROV) | 03-Jun-19 | Market Purchase (Planned) Duplicate | 5,424 | $7.71 | $41,814.70 | < 1% 22.77M to 22.78M | 110% |
03-Jun-19 6:13 PM View: | Urovant Sciences Ltd. (UROV) | 31-May-19 | Market Purchase (Planned) Duplicate | 5,071 | $7.70 | $39,042.10 | < 1% 22.77M to 22.77M | 111% |
03-Jun-19 6:13 PM View: | Urovant Sciences Ltd. (UROV) | 30-May-19 | Market Purchase (Planned) Duplicate | 7,251 | $8.01 | $58,089.50 | < 1% 22.76M to 22.77M | 102% |
29-May-19 6:12 PM View: | Urovant Sciences Ltd. (UROV) | 29-May-19 | Market Purchase (Planned) Duplicate | 6,882 | $7.55 | $51,983.20 | < 1% 22.75M to 22.76M | 115% |
29-May-19 6:12 PM View: | Urovant Sciences Ltd. (UROV) | 28-May-19 | Market Purchase (Planned) Duplicate | 3,807 | $7.68 | $29,244.60 | < 1% 22.75M to 22.75M | 111% |
29-May-19 6:12 PM View: | Urovant Sciences Ltd. (UROV) | 24-May-19 | Market Purchase (Planned) Duplicate | 3,796 | $7.70 | $29,233.40 | < 1% 22.75M to 22.75M | 111% |
23-May-19 6:21 PM View: | Urovant Sciences Ltd. (UROV) | 23-May-19 | Market Purchase Duplicate | 4,802 | $7.76 | $37,252.00 | < 1% 22.74M to 22.75M | 109% |
23-May-19 6:21 PM View: | Urovant Sciences Ltd. (UROV) | 22-May-19 | Market Purchase Duplicate | 5,033 | $8.06 | $40,557.90 | < 1% 22.74M to 22.74M | 101% |
23-May-19 6:21 PM View: | Urovant Sciences Ltd. (UROV) | 21-May-19 | Market Purchase Duplicate | 9,995 | $8.52 | $85,108.40 | < 1% 22.73M to 22.74M | 90% |
20-May-19 6:46 PM View: | Urovant Sciences Ltd. (UROV) | 20-May-19 | Market Purchase Duplicate | 10,000 | $8.05 | $80,524.80 | < 1% 22.72M to 22.73M | 101% |
20-May-19 6:46 PM View: | Urovant Sciences Ltd. (UROV) | 17-May-19 | Market Purchase Duplicate | 6,200 | $7.36 | $45,641.30 | < 1% 22.71M to 22.72M | 120% |
20-May-19 6:46 PM View: | Urovant Sciences Ltd. (UROV) | 16-May-19 | Market Purchase Duplicate | 5,408 | $6.79 | $36,718.20 | < 1% 22.7M to 22.71M | 139% |
19-Mar-19 4:49 PM View: | Sio Gene Therapies Inc. (SIOX) | 18-Mar-19 | Market Purchase Duplicate | 6,666,670 | $1.50 | $10,000,000.00 | 7% 99.29M to 105.95M | (72%) |
20-Dec-18 8:57 AM View: | Sio Gene Therapies Inc. (SIOX) | 18-Dec-18 | Market Purchase Duplicate | 10,000,000 | $1.00 | $10,000,000.00 | 11% 89.29M to 99.29M | (58%) |
03-Oct-18 7:18 PM View: | Urovant Sciences Ltd. (UROV) | 01-Oct-18 | Purchase Duplicate | 2,678,570 | $14.00 | $37,500,000.00 | 13% 20.03M to 22.7M | |
07-Jun-18 8:46 AM View: | Sio Gene Therapies Inc. (SIOX) | 05-Jun-18 | Market Purchase Duplicate | 14,285,700 | $1.75 | $25,000,000.00 | 19% 75.0M to 89.29M | (76%) |
04-Apr-18 5:00 PM View: | Myovant Sciences Ltd. (MYOV) | 02-Apr-18 | Market Purchase Duplicate | 1,110,020 | $20.27 | $22,500,000.00 | 3% 37.23M to 38.34M | 5% |